UK drug exports to US spared tariffs under deal critics say will cost NHS billions

‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments

British drug exports to the US will escape tariffs imposed by Donald Trump as part of a controversial UK-US medicines deal that critics fear will mean less money for the NHS.

The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more for particular treatments.